James Wilson

James Wilson

Chairman at CORCEPT THERAPEUTICS INCORPORATED

Net worth: 56 M $ as of 2024-03-30

80 year
Health Technology
Health Services
Commercial Services

Profile

James N.
Wilson
is currently the Chairman of Corcept Therapeutics, Inc. and a Director at The Palo Alto Medical Foundation.
He previously served as Chairman & CEO of Neurex Corp., CEO of Lifescan, Inc., Chairman of Tecan Genomics, Inc., Chairman of Amira Medical, Inc., and Lead Independent Director of Amylin Pharmaceuticals, Inc. He was also President & COO of Syntex Corp.
Wilson is a Director at A Stepping Stone Foundation and Insight Prison Project.
He holds undergraduate and MBA degrees from the University of Arizona.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-11-12 2,217,093 ( 2.14% ) 56 M $ 2024-03-30

James Wilson active positions

CompaniesPositionStart
CORCEPT THERAPEUTICS INCORPORATED Chairman 1998-12-31
The Palo Alto Medical Foundation Director/Board Member -
All active positions of James Wilson

Former positions of James Wilson

CompaniesPositionEnd
Chairman -
Director/Board Member 2009-05-31
Chairman 2000-12-31
Syntex Corp. President 1993-12-31
Chief Executive Officer 1989-12-31
See the detail of James Wilson's experience

Training of James Wilson

University of Arizona Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Wilson's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CORCEPT THERAPEUTICS INCORPORATED

Health Technology

Private companies9

Health Technology

Health Technology

Syntex Corp.

Health Technology

Electronic Technology

Health Technology

Health Services

The Palo Alto Medical Foundation

Health Services

Commercial Services

Commercial Services

See company connections